🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/2003 | 0,3531 USD |
| 03/09/2003 | 0,3531 USD |
| 20/08/2003 | 2,7443 USD |
| 04/06/2003 | 0,3435 USD |
| 05/03/2003 | 0,3435 USD |
| 04/12/2002 | 0,3435 USD |
| 04/09/2002 | 0,3435 USD |
| 05/06/2002 | 0,3340 USD |
| 06/03/2002 | 0,3340 USD |
| 05/12/2001 | 0,3340 USD |
| 30/08/2001 | 0,3340 USD |
| 31/05/2001 | 0,3244 USD |
| 07/03/2001 | 0,3244 USD |
| 06/12/2000 | 0,3244 USD |
| 30/08/2000 | 0,3244 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/01/1975 | 1,69 | 1,72 | 1,66 | 1,67 | -1,18% | 3,53% | 2.278.771 |
| 10/01/1975 | 1,70 | 1,74 | 1,67 | 1,69 | -0,59% | 4,10% | 3.203.107 |
| 09/01/1975 | 1,71 | 1,71 | 1,66 | 1,70 | -1,91% | 3,29% | 2.950.330 |
| 08/01/1975 | 1,76 | 1,77 | 1,72 | 1,73 | -1,51% | 2,83% | 1.924.128 |
| 07/01/1975 | 1,79 | 1,82 | 1,76 | 1,76 | -2,03% | 3,51% | 1.501.574 |
| 06/01/1975 | 1,79 | 1,84 | 1,78 | 1,79 | +0,00% | 2,96% | 1.305.389 |
| 03/01/1975 | 1,78 | 1,81 | 1,76 | 1,79 | +0,56% | 2,60% | 988.474 |
| 02/01/1975 | 1,76 | 1,81 | 1,76 | 1,78 | +1,32% | 2,45% | 1.648.714 |
| 31/12/1974 | 1,70 | 1,76 | 1,70 | 1,76 | +4,12% | 3,71% | 1.252.570 |
| 30/12/1974 | 1,69 | 1,69 | 1,67 | 1,69 | -0,39% | 1,37% | 1.380.845 |
| 27/12/1974 | 1,74 | 1,74 | 1,68 | 1,70 | -2,66% | 3,80% | 3.520.022 |
| 26/12/1974 | 1,79 | 1,81 | 1,73 | 1,74 | -2,59% | 4,26% | 2.878.646 |
| 24/12/1974 | 1,77 | 1,79 | 1,77 | 1,79 | +1,12% | 0,93% | 565.920 |
| 23/12/1974 | 1,76 | 1,78 | 1,75 | 1,77 | +0,37% | 2,07% | 1.535.530 |
| 20/12/1974 | 1,77 | 1,78 | 1,75 | 1,76 | -0,37% | 1,50% | 980.928 |
| 19/12/1974 | 1,78 | 1,79 | 1,76 | 1,77 | -0,38% | 1,86% | 1.116.749 |
| 18/12/1974 | 1,78 | 1,82 | 1,78 | 1,78 | +0,00% | 2,42% | 1.226.160 |
| 17/12/1974 | 1,74 | 1,79 | 1,73 | 1,78 | +1,91% | 3,42% | 1.875.082 |
| 16/12/1974 | 1,77 | 1,78 | 1,73 | 1,74 | -1,31% | 3,00% | 1.165.795 |
| 13/12/1974 | 1,76 | 1,80 | 1,76 | 1,77 | +0,56% | 2,45% | 1.633.622 |
| 12/12/1974 | 1,78 | 1,81 | 1,75 | 1,76 | -1,12% | 2,98% | 3.240.835 |
| 11/12/1974 | 1,74 | 1,79 | 1,74 | 1,78 | +2,68% | 2,86% | 2.644.733 |
| 10/12/1974 | 1,70 | 1,76 | 1,70 | 1,73 | +3,58% | 3,71% | 1.494.029 |
| 09/12/1974 | 1,60 | 1,67 | 1,59 | 1,67 | +4,13% | 4,75% | 2.241.043 |
| 06/12/1974 | 1,67 | 1,67 | 1,58 | 1,60 | -3,96% | 5,35% | 2.158.042 |
| 05/12/1974 | 1,73 | 1,73 | 1,67 | 1,67 | -3,64% | 3,64% | 799.834 |
| 04/12/1974 | 1,70 | 1,74 | 1,70 | 1,73 | +1,95% | 2,14% | 1.377.072 |
| 03/12/1974 | 1,73 | 1,73 | 1,69 | 1,70 | -2,28% | 2,11% | 1.565.712 |
| 02/12/1974 | 1,80 | 1,80 | 1,73 | 1,74 | -4,20% | 3,86% | 1.094.112 |
| 29/11/1974 | 1,79 | 1,83 | 1,78 | 1,82 | +1,48% | 2,78% | 973.382 |